EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biobanks: can they overcome controversy and deliver on their promise to unravel the origins of common diseases?






Medical Education 40(6): 500-502

Biobanks: can they overcome controversy and deliver on their promise to unravel the origins of common diseases?



Accession: 048378911

PMID: 16700763

DOI: 10.1111/j.1365-2929.2006.02494.x



Related references

Onisto, M.; Ananian, V.; Caenazzo, L., 2012: Biobanks between common good and private interest: the example of umbilical cord blood private biobanks. Storage of human biological samples and personal data associated with them is organised in Biobanks. In spite of expectation given by biobanks in medicine, their management involved some ethical questions, for example, the need for policies to reg...

Petersen, A., 2009: The ethics of expectations: biobanks and the promise of personalised medicine. Expectations play a major role in 'driving' biotechnology research and development. However, their ethical significance has been largely overlooked. This article examines the dynamics and ethics of expectations surrounding biotechnologie...

Murtagh, M.J.; Demir, I.; Harris, J.R.; Burton, P.R., 2011: Realizing the promise of population biobanks: a new model for translation. The <i>promise</i> of science lies in expectations of its benefits to societies and is matched by expectations of the realisation of the significant public investment in that science. In this paper, we undertake a methodological analys...

Foster, M.W.; Sharp, R.R., 2005: Will investments in large-scale prospective cohorts and biobanks limit our ability to discover weaker, less common genetic and environmental contributors to complex diseases?. Increasing the size of prospective cohorts and biobanks is one approach to discovering previously unknown contributors to complex diseases, but it may come at the price of concealing contributors that are less common across all the participants in...

Brante, T.; Hallberg, M., 1990: An analysis of the debate on the concept of death as an instrument to unravel controversy. Lakartidningen 87(7): 462-462

Price, A.L.; Spencer, C.C.A.; Donnelly, P., 2015: Progress and promise in understanding the genetic basis of common diseases. Susceptibility to common human diseases is influenced by both genetic and environmental factors. The explosive growth of genetic data, and the knowledge that it is generating, are transforming our biological understanding of these diseases. In thi...

Northridge, M.E.; Healton, C.G., 2012: Who will deliver on the promise?. The Doctor of Public Health (DrPH) Core Competency Model aspires to rigorously train future leaders of public health practice to direct and advance societal efforts that address socially rooted causes of health and illness. Although there is no pr...

Wright, J., 2014: Deliver on a promise. Scientific American 311(1): S12-S13

Maloney William V., 2004: Statoil; we deliver what we promise. After 30 years as the Norwegian national oil company, Statoil was listed on the New York and Oslo stock exchanges in June 2001. Since 1999, Statoil has had a significant shift in commercial and portfolio thinking. During the period from the IPO un...

Saint-Raymond, A.; Herold, R., 2013: Medicines for pediatric oncology: can we overcome the failure to deliver?. Expert Review of Clinical Pharmacology 5(5): 493-495